Remdesivir de (ethylbutyl 2-aminopropanoate)
Remdesivir de (ethylbutyl 2-aminopropanoate) is an impurity of Remdesivir. Remdesivir, a nucleoside analogue with effective antiviral activity, has EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro[1][2].
Product Specifications
CAS Number
2607871-93-0
UNSPSC
12352005
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/remdesivir-de-ethylbutyl-2-aminopropanoate.html
Solubility
10 mM in DMSO
Smiles
N#C[C@@]([C@@H]([C@@H]1O)O)(C2=CC=C3N2N=CN=C3N)O[C@@H]1CO[P](OC4=CC=CC=C4)(O)=O
Molecular Formula
C18H18N5O7P
Molecular Weight
447.34
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 / ICAM3 (CG106), CF640R conjugate, 0.1mg/mL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF594 conjugate, 0.1mg/mL
CD44 Standard (DF1485), CF680 conjugate, 0.1mg/mL
MAGE A1 (MA454), CF405S conjugate, 0.1mg/mL
GAD1 / GAD67 (GABAergic Neuronal Marker) (GAD1/2563), CF488A conjugate, 0.1mg/mL
